Senators Collins, King Announce More Than $4 Million For Neurologic, Alzheimer’s Research

 WASHINGTON, D.C. – U.S Senators Susan Collins, Chairman of the Senate Special Committee on Aging, and Angus King announced today that the U.S. Department of Health and Human Services has awarded two separate grants totaling $4,010,936 in support of neurological disorder research to be conducted at the University of New England as well as Alzheimer’s disease research at Jackson Laboratory.
 
      “Families in Maine and around the nation work tirelessly every day to support loved ones with Alzheimer’s disease and other neurological disorders, and this funding is crucial to helping them with those challenges and improving lives,” said Senators Collins and King in a joint statement. “The more we learn about these diseases, the more that can be done to improve management, treatment and prevention. Maine is fortunate to have institutions like Jackson Labs and the University of New England working diligently on these critical issues, and these research grants will help to ensure that they have the resources they need to continue their work to improve human health.”
 
      As Chairman of the Senate Aging Committee, Senator Collins has placed fighting Alzheimer’s disease among her highest priorities. Earlier this year, with Senator Collins' strong support, the Senate Appropriations Committee approved a $350 million increase in funding for Alzheimer’s research. Both Senators Collins and King are cosponsors of the Health Outcomes, Planning, and Education (HOPE) for Alzheimer’s act, a bill that would ensure that patients and their families have the information they need to combat this difficult disease.
 
      The awards are as follows:
 

          Jackson Laboratory: $3,567,446
          University of New England: $443,490